Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemcitabine, Paclitaxel, and piritrexim: a phase I study.
Liu G, Bailey HH, Arzoomanian RZ, Alberti D, Binger K, Volkman J, Feierabend C, Marnocha R, Wilding G, Thomas JP. Liu G, et al. Among authors: volkman j. Am J Clin Oncol. 2003 Jun;26(3):280-4. doi: 10.1097/01.coc.0000081607.16287.6f. Am J Clin Oncol. 2003. PMID: 12796601 Clinical Trial.
Phase I trial of perillyl alcohol administered four times daily continuously.
Morgan-Meadows S, Dubey S, Gould M, Tutsch K, Marnocha R, Arzoomanin R, Alberti D, Binger K, Feierabend C, Volkman J, Ellingen S, Black S, Pomplun M, Wilding G, Bailey H. Morgan-Meadows S, et al. Among authors: volkman j. Cancer Chemother Pharmacol. 2003 Nov;52(5):361-6. doi: 10.1007/s00280-003-0684-y. Epub 2003 Aug 2. Cancer Chemother Pharmacol. 2003. PMID: 12904896 Clinical Trial.
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.
McNeel DG, Eickhoff J, Lee FT, King DM, Alberti D, Thomas JP, Friedl A, Kolesar J, Marnocha R, Volkman J, Zhang J, Hammershaimb L, Zwiebel JA, Wilding G. McNeel DG, et al. Among authors: volkman j. Clin Cancer Res. 2005 Nov 1;11(21):7851-60. doi: 10.1158/1078-0432.CCR-05-0262. Clin Cancer Res. 2005. PMID: 16278408 Clinical Trial.
A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose.
Holen KD, Belani CP, Wilding G, Ramalingam S, Volkman JL, Ramanathan RK, Vasist LS, Bowen CJ, Hodge JP, Dar MM, Ho PT. Holen KD, et al. Among authors: volkman jl. Cancer Chemother Pharmacol. 2011 Feb;67(2):447-54. doi: 10.1007/s00280-010-1346-5. Epub 2010 May 12. Cancer Chemother Pharmacol. 2011. PMID: 20461380 Free PMC article. Clinical Trial.
The importance of 'dread risk' for vaccine communication.
Day AM, Volkman JE. Day AM, et al. Among authors: volkman je. J Commun Healthc. 2024 Aug 26:1-8. doi: 10.1080/17538068.2024.2393918. Online ahead of print. J Commun Healthc. 2024. PMID: 39186246
Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study.
Park LK, Lim KH, Volkman J, Abdiannia M, Johnston H, Nigogosyan Z, Siegel MJ, McGill JB, McKee AM, Salam M, Zhang RM, Ma D, Popuri K, Chow VTY, Beg MF, Hawkins WG, Peterson LR, Ippolito JE. Park LK, et al. Among authors: volkman j. Cancer Metab. 2023 May 18;11(1):6. doi: 10.1186/s40170-023-00306-2. Cancer Metab. 2023. PMID: 37202813 Free PMC article.
75 results